NEWS

Written by :
Posted on :

September 16, 2024

Kolosis Recognized as Utah Fast 50 Emerging Company

Kolosis is proud to announce their recognition on the Utah Business 2024 Fast 50 – Emerging Companies list of the state’s fastest growing companies. This is the second consecutive year that Kolosis received this recognition.

Fast 50 companies are companies five years or older that are selected based on a combination of revenue growth and total revenue.  In addition to the Fast 50, Utah Business also recognizes emerging companies— companies who have not been in business the required five years, but who have demonstrated exponential growth.

Kolosis, a leading provider of orthobiologics, ranked among the emerging companies recognized by Utah Business for making impactful contributions in the industry. This recognition reflects the company’s strategic vision, operational excellence, and the efforts of its dedicated team, solidifying Kolosis as a strong competitor in the biologics market. Kolosis has shown impressive growth throughout 2024 and expects to maintain this momentum.

About Kolosis BIO:

Kolosis BIO is a leading provider of innovative biologic solutions, dedicated to commercializing cutting-edge technologies and delivering market-leading products to the orthopedic industry. As a pure-play biologics company, Kolosis BIO exclusively partners with MTF Biologics to offer superior quality bone graft technologies such as Kore Fiber, a 100% cortical fiber allograft and Prime HD, a pre-hydrated DBM. These allografts are backed by MTF’s proprietary aseptic processing methods that optimally preserve matrix structures and osteoinductive properties.

As the company looks to the future, Kolosis is dedicated to driving innovation in the biologics field, expanding its product offerings and pushing the boundaries of science to enhance patient outcomes. With a focus on relentless execution and bold technologies, Kolosis BIO endeavors to become a leading force in the biologics market. For more information, please visit www.kolosis.com.

About MTF Biologics:

MTF Biologics is a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients and advancing science. They provide unmatched service, resources, and expertise to donors and their loved ones who give the gift of donation, people who depend on tissue and organ transplants, healthcare providers, and clinicians and scientists.

The International Institute for the Advancement of Medicine (IIAM), a Division of MTF Biologics, honors donors of non-transplantable organs by providing their gifts to the medical research community to combat and cure diseases. Statline, also a Division of MTF Biologics, provides specialized communications and technology expertise to organ, tissue, and eye procurement organizations, as well as the hospitals and patients that they serve. Its sister organization, Deutsches Institute for Zell-und Gewebeersatz – DIZG (The German Institute for Cell and Tissue Transplantation), expands its reach to patients across the globe. For more information, visit www.mtfbiologics.org.